$15,000 of AXOGEN INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues relating to sensation loss after mastectomy."
You can find more data on corporate lobbying on Quiver Quantitative.
AXGN Insider Trading Activity
AXGN insiders have traded $AXGN stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $AXGN stock by insiders over the last 6 months:
- ERICK WAYNE DEVINNEY (Chief Innovation Officer) sold 15,111 shares for an estimated $264,442
- AMY MCBRIDE WENDELL sold 5,000 shares for an estimated $100,100
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AXGN Hedge Fund Activity
We have seen 79 institutional investors add shares of AXGN stock to their portfolio, and 83 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC removed 828,410 shares (-86.3%) from their portfolio in Q4 2024, for an estimated $13,652,196
- DRIEHAUS CAPITAL MANAGEMENT LLC added 595,579 shares (+166.0%) to their portfolio in Q4 2024, for an estimated $9,815,141
- MORGAN STANLEY removed 469,947 shares (-16.2%) from their portfolio in Q4 2024, for an estimated $7,744,726
- FIRST LIGHT ASSET MANAGEMENT, LLC added 416,499 shares (+10.2%) to their portfolio in Q4 2024, for an estimated $6,863,903
- BALYASNY ASSET MANAGEMENT L.P. added 299,942 shares (+inf%) to their portfolio in Q4 2024, for an estimated $4,943,044
- INVESCO LTD. removed 260,294 shares (-93.8%) from their portfolio in Q4 2024, for an estimated $4,289,645
- JPMORGAN CHASE & CO removed 238,432 shares (-43.4%) from their portfolio in Q4 2024, for an estimated $3,929,359
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
